RE: AGM4 Oct 2023 13:14
val, well most small companies won’t unless there is another covid like event. however, that’s irrelevant, ncyt have the money and are doing nothing with it (your gene acquisition is a massive risk so will see how that pans out) and it is being burned at an alarming rate.
and where is the extra £30m a year from? are you referring to joint revenue, you do realise that revenue doesn’t equal cash in the bank, we have **** loads of overheads to pay for.
hc - precisely, and yet again they proved why with that awful presentation last week. if justice is served they’ll be kicked out tomorrow but we know it work. i’ve not even been able to vote. pathetic.
i’d say it’s more 36-48 months given the speed we move, don’t forget we’re miles below 2019 revenues, your gene is loss making and comes with an expensive executive who may not see eye to eye with the current crop, could cause delays. you’re right that there’s no use investing based on cash in the bank as that looks like it’ll be gone in 4 years.